Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000513873 | SCV000202324 | uncertain significance | not provided | 2016-06-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000513873 | SCV000521007 | benign | not provided | 2018-11-19 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 18513263, 20129625) |
Center for Pediatric Genomic Medicine, |
RCV000513873 | SCV000610075 | benign | not provided | 2017-08-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080277 | SCV000656728 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000059295 | SCV001141012 | benign | Episodic ataxia type 2 | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000513873 | SCV001151715 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | CACNA1A: PP2, BS1, BS2 |
Athena Diagnostics | RCV000152897 | SCV001880042 | benign | not specified | 2021-01-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002426621 | SCV002742299 | likely benign | Inborn genetic diseases | 2017-06-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003985266 | SCV004772874 | likely benign | CACNA1A-related disorder | 2020-07-03 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Uni |
RCV000059295 | SCV000090847 | not provided | Episodic ataxia type 2 | no assertion provided | not provided |